- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
化瘀止痛胶囊合脐止痛散配合治疗子宫腺肌病的临床研究
The Clinical Research on the Effect of HuaYuZhiTong Capsule and
FuQiZhiTong Powder in Treating Adenomyosis
Speciality: Gynecology of TCM, The study of menstruation sickness and sterility
Tutor: Professor Ye Qing
Author: Zhang Jing
Abstract
Objective: Observe the clinical curative effect of HuaYuZhiTong Capsule combined
with FuQiZhiTong Powder, which is applied to treat adenomyosis dysmenorrhea and
explore its work mechanism. Methods: We totally observed 65 patients of adenomyosis
and it was divided into two groups randomly. The treatment group take HuaYuZhiTong
Capsule combined with FuQiZhiTong Powder, while the control group takes SanJie
ZhenTong capsule and HuaJi, which are compared to observe their curative effects and
impacts on CA125 、prostaglandin E2 and tumor necrosis factor - α. Results: After
treatment, the dysmenorrhea level score of the two groups were obviously decreased
(P0.05) but there were no significant differences between groups (P >0.05). The
syndrome score of the treatment group has significant difference (P0.05 or P0.01) ,
while mostly of the control group was the same as before. The Uterine volume、CA125 and
prostaglandin E2 of the treatment group is obviously decreased after treating, which has
significant differences compared with its original level (P0.05 or P0.01) and the
prostaglandin E2 of the control grouphas significant differences compared with its original
level (P0.01). The tumor necrosis factor – α level of the treatment group is obviously
decreased after treating, which has significant differences compared with its original level
(P0.01) and the control group (P0.01). Conclusion: HuaYuZhiT
您可能关注的文档
- 健脾祛痰方改善力衰竭患者胃肠功能不全的研究.pdf
- 健脾补肾方联合p方案治疗术后非小细胞肺癌的临床研究.pdf
- 健脾补肾,祛瘀痰法治疗原发痛风性关节炎慢性期的临床观察.pdf
- 健脾补肾法治疗髓增生异常综合征ra型的临床观察.pdf
- 健脾运湿法对单性肥胖糖调节受损脾虚不运证患者血清胰高血糖素样肽-1、抵抗素、胰岛素水平的影响.pdf
- 健脾调中汤治疗能性消化不良(脾胃虚弱型)的临床研究.pdf
- 健膝丸对大鼠膝关节炎sod、mda、no的影响.pdf
- 健骨方对兔膝骨节炎软骨的影响及治疗膝骨关节炎的临床观察.pdf
- 儿童急性扁桃体中医休质与证型的相关性研究.pdf
- 儿童注意力缺陷动障碍证候学研究.pdf
文档评论(0)